B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid Tumors.
Siok Ping YeoLindsay KuaJin Wei TanJoanna Kristyn LimFiona Hs WongMay Delos SantosChek-Meng PohAngeline Xh GohXin Yu KohXiaohua ZhouRavisankar RajarethinamQingfeng ChenZhisheng HerIvan D HorakLionel LowKar Wai TanPublished in: Cancer research communications (2024)
Clinical application of EBVSTs armored with B7-H3-targeting CARs offer an attractive solution to translate off-the-shelf CAR T cells as therapy for solid tumors.